Summary Background: The 6 min walk test (6MWT) provides prognostic information in various respiratory diseases, but limited data exist in cystic fibrosis (CF) adults. Methods: Consecutive CF adults who performed 6MWT at Cochin Hospital (Paris, France) over 12 years were analyzed. The cut-off 6 min walking distance (6MWD) value that best predicted a combined endpoint (death without transplant or lung transplant) was established using a receiver operating curve. Determinants of low 6MWD or of desaturation (SpO 2 90%) during 6MWT were examined using multivariate logistic regressions. Prognostic value of these variables was assessed using KaplaneMeier and Cox analyses. Results: 6MWT was performed in 286 CF adults (median: age, 28 yr; FEV 1 , 45% predicted) of whom 14% (n Z 40) had lung transplant and 6% (n Z 18) died without transplant. 6MWD correlated with FEV 1 % predicted (r Z 0.43; P < 0.001), but markedly differed in subjects within the same range of FEV 1 . A 6MWD 475 m predicted death or transplant and was mostly found in patients with FEV 1 60% predicted. Desaturation during the 6MWT occurred in 29% of patients, exclusively in subjects with FEV 1 60% predicted. Both 6MWD 475 m and desaturation during the 6MWT were independent predictors of death or transplant.
Introduction
Cystic fibrosis (CF) in adults is usually characterized by respiratory disease with bronchiectasis and chronic airway infection. Structural abnormalities characterized by airway remodeling and mucus plugging lead to progressive airflow limitation [1] , often resulting in respiratory failure and in the need for lung transplant [2] . Although a forced expiratory volume in 1 s (FEV 1 ) <30%, a marker of the severity of airflow limitation, has been initially proposed for considering lung transplant in CF patients [3] , CF patients with very severe airflow limitation may have prolonged survival without transplant [4] . Because CF is a multiorgan disease, it has been suggested that combination of respiratory and extra-respiratory variables may help in the prognostic evaluation of CF adults [5] .
The 6 min walk test (6MWT) is a practical simple test that evaluates the global and integrated response of all the systems involved during exercise, including the pulmonary and cardiovascular systems, systemic circulation, peripheral circulation, blood, neuromuscular units, and muscle metabolisms [6] . The test has been initially used in the preoperative and postoperative evaluation and in the evaluation of therapeutic intervention (e.g., pulmonary rehabilitation) [6] . Subsequently, it has been used to gain prognostic information in various chronic respiratory diseases including pulmonary hypertension [7] , idiopathic pulmonary fibrosis [8] , and chronic obstructive pulmonary disease (COPD) [9] .
The clinical value of 6MWT in CF adults has been seldom studied. Most studies were performed in small cohorts of subjects with a narrow range of airflow limitation (either in subjects with mild airflow limitation [10e12] or in the evaluation of candidates for lung transplant [13, 14] ). At this time, studies of 6MWT in large cohorts of CF adults with a wide range of airflow limitation have not been performed, and the prognostic value of the 6MWT in CF adults has not been established.
The aims of the present study were (A) to describe 6 min walking distance (6MWD) and oxygen saturation (SpO 2 ) during the 6MWT in a large cohort of adult CF patients with a wide range of airflow limitation (B) to examine the determinants of a low 6MWD and those of desaturation during the 6MWT (C) to determine whether data obtained during the 6MWT provide additional prognostic information compared to usual predictors of survival.
Methods Patients
Consecutive CF adults (age > 18 yr) who underwent at least one 6MWT at Cochin Hospital (Paris, France) from October 2000 to January 2012 were included in the analysis. CF was diagnosed on the basis of clinical manifestations, sweat chloride concentrations and genetic findings [15] . Characteristics were recorded while the patients were in stable state at the time of the first 6MWT. Data included age, gender, age at diagnosis of CF, CFTR mutations, pancreatic status, diabetes mellitus, liver cirrhosis, oxygen dependence, use of non-invasive ventilation, chronic airway bacterial colonization with Pseudomonas aeruginosa or Burkholderia cepacia, and body mass index (kg/m 2 ). Vital status (alive without lung transplant, dead without lung transplant, transplanted) was assessed as per January 31st 2012. The study conformed to the Declaration of Helsinki and was approved by the Institutional Review Board of the French Learned Society for Respiratory MedicineeSociété de Pneumologie de Langue Française-(IRB#, 2012-013).
Six minute walk and pulmonary function tests
The 6MWT was performed indoors, along a flat straight 50 m corridor supervised by a trained researcher, according to the ATS guidelines [6] . A practice 6MWT was not performed. All 6MWT were performed with pulse oximetry for continuous recording of oxygen saturation (SpO 2 ). Dyspnea was assessed using the Borg scale each minute during the 6MWT and maximum dyspnea level was recorded [6] . Patients were encouraged every minute using the standardized recommended sentences: "you are doing well" or "keep up the good work". Patients were allowed to stop during the test, but were instructed to resume the walking as soon as they felt able to do so. Pulmonary function data were obtained using whole-body plethysmography with standardized equipment (Jaeger) according to ATS/ERS consensus guidelines. All pulmonary function data were obtained as absolute values and expressed as % predicted of reference values [16] .
Statistical analysis
Data were reported as median and interquartile range [IQR] or n (%). The cut-off 6MWD value that best predicted death without transplant or lung transplant was determined from a receiver operating curve (ROC), using maximum Youden indice. Desaturation during the 6MWT was defined as a SpO 2 90% during the test. Univariate and multivariate stepwise logistic regressions were used to examine which independent factors were associated with low 6MWD ( 475 m) or with desaturation (SpO 2 90%) during 6MWT. All variables with a P 0.20 in univariate analyses were entered in the models. Time to death or lung transplant was studied using KaplaneMeier estimates and comparisons between curves were performed using a log-rank test. Multivariate analysis of variables associated with death without transplant or lung transplant was performed with a Cox proportional hazard model. In this analysis, FEV 1 % predicted was forced into the model to examine which variables provided additional prognostic information when added to FEV 1 , a usual predictor of lung transplantation or mortality in CF patients [3] . Statistical analyses were 2-sided and P < 0.05 was considered statistically significant. Analyses were performed using the SAS package version 9.2 (SAS Institute, Cary, NC).
Results

Patients
Characteristics of 286 adult CF patients are presented in Table 1 . Very severe airflow limitation (FEV 1 < 30% predicted) was found in 23% (n Z 66) patients, severe airflow limitation (30 FEV 1 < 60% predicted) in 45% (n Z 129) patients, and moderate airflow limitation (FEV 1 ! 60% predicted) in 32% (n Z 91) patients. SpO 2 at rest was 90% in 6% (n Z 17) patients, including 9 patients with SpO 2 at rest Z 90%, 4 patients with SpO 2 at rest Z 89%, and 4 patients with SpO 2 at rest 88%. Median [IQR] follow-up after the 6MWT was 723 [384; 1496] days. At the end of follow-up, 80% (n Z 228) patients were alive without transplant, 14% (n Z 40) had received lung transplant, and 6% (n Z 18) had died without transplant.
Six minute walk test
A six minute walk test was performed in room air in 272 patients. Oxygen supplementation during the test was provided in 14 patients (all with FEV 1 30% predicted), including 8 patients with SpO 2 at rest 89% and in 6 patients with 90% SpO 2 at rest 92%. All 14 patients who received oxygen supplementation during the 6MWT had SpO 2 at rest with oxygen supplementation !92%, but desaturation (SpO 2 90%) during the test occurred in all 14 patients (SpO 2 min 84 [81e86]%). These latter patients were kept in the analyses because the exclusion of these patients with severe disease would have introduced bias in prognosis analyses.
The median [IQR] 6MWD was 526 [460; 584] m. The 6MWD correlated with FEV 1 % predicted (Pearson r Z 0.43; P < 0.001); median 6MWD were 574 m, 522 m and 458 m in subjects with moderate, severe and very severe airflow limitation, respectively. In patients who performed 6MWT under oxygen supplementation (n Z 14), the median 6 MWD was 370 m. Marked heterogeneity in 6MWD was found within each group of patients with similar range of airflow limitation (see Fig. 1 ). Based on a receiving operating curve (see Fig. 2 ), the cut-off 6MWD value that best predicted death or lung transplant was 472 m. From a clinical point of view, we defined a low 6MWD as 475 m. A 6MWD 475 m was found in 29% (n Z 84) patients, including 59% (n Z 39/ 66) patients with FEV 1 <30% predicted, 26% (n Z 33/129) patients with 30% FEV 1 < 60% predicted, and 13% (n Z 12/91) patients with FEV 1 !60% predicted (P < 0.0001, chi-square test). Variables associated with a 6MWD 475 m in univariate and multivariate analyses are presented in Table 2 . In multivariate analysis, only FEV 1 % predicted (P Z 0.0003) and SpO 2 at rest (P Z 0.06) were predictors of 6MWD.
Desaturation, as defined by a SpO 2 90% during the 6MWT, was found in 83 (29%) patients, including all patients (n Z 14) who had oxygen administration during the 6MWT. The relationship between minimal SpO 2 during 6MWT and FEV 1 % predicted is shown in Fig. 3 . Although all patients with desaturation had a FEV 1 60% predicted, several patients with very severe airflow limitation had no desaturation. Variables associated with a SpO 2 90% during the 6MWT in univariate and multivariate analyses are presented in Table 3 . In multivariate analysis, variables associated with desaturation during the 6MWT were SpO 2 at rest, FEV 1 % predicted, residual volume (RV)/total lung capacity (TLC), liver cirrhosis and body mass index (BMI).
Prognostic value of 6MWD and desaturation during 6MWT
KaplaneMeier analyses of the risk of death or lung transplant according to 6MWD and to SpO 2 during 6MWT are shown in Fig. 4 . A 6MWD 475 m or a SpO 2 90% during the 6MWT were associated with higher risk of death or lung transplant (both analyses, P < 0.001). To further examine whether data obtained during the 6MWT were independent predictors of death or lung transplant, we performed a Cox analysis. Multivariate predictors of death or lung transplant were airway colonization with B. cepacia, 6MWD 475 m, SpO 2 90% during the 6MWT and level of dyspnea (Borg scale) during the 6MWT, whereas higher FEV 1 % predicted was associated with improved survival (see Table 4 ).
Discussion
In the present study, we examined the prognostic value of 6MWT in a large single center cohort of CF adults. We found that a low 6MWD ( 475 m) or a desaturation (SpO 2 90%) during the 6MWT were associated with increased risk of death without transplant or lung transplant. Importantly, these variables remained associated with death without transplant or lung transplant in a multivariate Cox analysis taking into account usual predictors of poor outcome in CF adults. These data suggest that the 6MWT provides important prognostic information in CF adults. The 6MWD correlated with FEV 1 (% predicted), indicating that exercise capacity decreased with increasing airflow limitation in CF adults. This finding is consistent with the results of previous studies that assessed the 6MWD in smaller cohorts of CF adults. For example, Chetta et al. reported that the mean AESD 6MWD was 626 AE 49 m in 25 CF adults with moderate airflow limitation (FEV 1 , 69 AE 23% predicted) [10] , whereas Coloni et al. reported that the 6MWD was 320 AE 90 m in a series of 109 CF adults referred for lung transplant (FEV 1 , 20 AE 5% predicted) [13] . In the present study, the relatively large sample size and the wide range of airflow limitation allowed identifying 6MWD variability in subjects with similar range of airflow limitation. In fact, there was considerable overlap in 6MWD between CF adults with different range of airflow limitation, suggesting that FEV 1 was not the only determinant of 6MWD in CF adults. Thus, both FEV 1 % predicted (P Z 0.003) and SpO 2 at rest (P Z 0.06) were associated with a low 6MWD in multivariate analysis, whereas other variables including Figure 1 Distribution of 6MWD according to the severity of airflow limitation. Adult CF subjects were classified according to the range of airflow limitation, as follows: very severe airflow limitation (FEV 1 , % predicted <30%; n Z 66 patients; upper panel), severe airflow limitation (30 FEV 1 , % predicted <60%; n Z 129 patients; middle panel) and moderate airflow limitation (FEV 1 , % predicted !60%; n Z 91 patients; lower panel). In each group, the distribution of 6MWD followed a normal distribution (KolmogoroveSmirnov test >0.05).
Figure 2
Receiver operating curve of 6MWD. The receiver operating curve (ROC) is a mathematical function of the sensitivity and specificity of the 6MWD. The best value for death or lung transplant prediction (including 18 deaths and 40 lung transplants) was 472 m, which provided a 60% sensitivity and 79% specificity. From a clinical perspective, the cut-off value of 475 m was chosen as representing a low 6MWD. force, age and body weight on 6MWD [12] . Differences between both studies may be, at least in part, related to baseline characteristics of the cohorts (e.g., number of patients, severity of airflow limitation) and to the inclusion of different covariates in the analyses. Our study revealed that desaturation (SpO 2 90%) during the 6MWT occurred exclusively in subjects with FEV 1 60%, although a group of subjects with very severe airflow limitation (FEV 1 <30% predicted) had no desaturation. The main determinants of desaturation during the 6MWT were FEV 1 % predicted and SpO 2 at rest, which were also associated with 6MWD. However, the findings that trapped gas (RV/TLC), nutritional status (BMI) and liver cirrhosis (presumably through intrapulmonary shunts) were also determinants of desaturation during the 6MWT clearly indicated that 6MWD and desaturation during the 6MWT explore different aspects of disease in CF adults.
To the best of our knowledge, the present study is the first to examine prognostic value of 6MWD in CF adults. We found that a 6MWD 475 m best predicted death without transplant or lung transplant. This 6MWD cut-off is markedly higher than the 334 m described to predict mortality in patients with chronic obstructive pulmonary disease (COPD) [9] and the 207 m that predicted mortality in patients with severe idiopathic pulmonary fibrosis (IPF) [17] , respectively. The relatively high 6MWD that served as a cut-off to predict death without transplant or lung transplant in CF adults is likely explained by the younger age of these subjects compared to those with other chronic respiratory diseases.
The present study is the largest observational study of 6MWT in CF adults. Although the analysis was retrospective, all data were prospectively collected and survival information was available in all patients. In this single center study, 6MWT were performed under standardized condition following international guidelines [6] . Although 6MWD may vary with demographic characteristics (e.g., age, gender, body weight or height) in healthy adults [18] , no relationship was found between these variables and 6MWD in our study. Thus, 6MWD was presented in absolute distance rather than using % predicted of values obtained in healthy controls [18] . The desaturation cut-off (SpO 2 90% during the 6MWT) that was chosen in this study predicted survival without transplant. Although the cut-off value was chosen based on clinical judgment rather than based on statistical analysis, this criteria provided increased prognostic value to the 6MWD. The outcome used for prognostic analyses was death without transplant or lung transplant, reflecting the fact that most CF patients underwent transplantation at a time when they had a very high risk of dying. Nevertheless in a sensitivity analysis, we found that a 6MWD 475 m and a SpO 2 min 90% remained independent predictors of death (no transplantation, n Z 18) in multivariate analysis (HR 2.80 [1.03; 7.66], P Z 0.04 and HR 3.43 [1.21; 9.67] P Z 0.02, respectively). Finally, the 2002 ATS statement suggest that a practice 6MWT should be considered, but no practice 6MWT was performed in the present study [6] . This recommendation was based on a learning effect that only increased modestly the 6MWD during a second 6MWT in most diseases [6] . Ziegler et al. examined the repeatability of the 6MWT in 31 adolescents and adults with CF, by performing a first 6MWT followed by a second Figure 3 Relationship of FEV 1 , % predicted to desaturation during the 6MWT. Minimal SpO 2 during the 6MWT was recorded and desaturation was defined as a SpO 2 90% (vertical line). Desaturation was observed exclusively in subjects with an FEV 1 60% predicted (horizontal line). However, a subgroup of subjects (lower right quadrant) with an FEV 1 <30% predicted had no desaturation during the 6MWT. 6MWT after 60 min of rest [19] . The mean difference between a first and a second test was À6.5 m and the mean SpO 2 difference was 0.6%, indicating that results obtained during a 6MWT were reproducible [19] . Because 4/31 (13%) patients had differences in 6MWD that exceeded 54 m, the authors suggested that two 6MWT are required on any occasion to obtain a reliable estimate of the 6MWD in CF patients [19] . Although our data should be interpreted in this context, the absence of a practice test was present equally in all patients, which presumably limited the impact on our conclusion.
Assessing the prognosis of CF adults has proven difficult. Early studies suggested that a FEV 1 30% predicted should prompt lung transplant [3] , but further studies showed that CF adults may have prolonged survival at low lung function [4] . A comprehensive model that used multiple clinical data (e.g., age, nutritional status, FEV 1 , exacerbations, microbiological data) provided no better diagnostic accuracy than the simpler FEV 1 criterion for predicting mortality [20] , and predicting poor outcome in CF adults remains a challenge [21] . Current guidelines for considering lung transplant in CF adults do not take into account the 6MWT [5, 22] . We suggest that data obtained during the 6MWT may help in identifying CF adults with severe airflow limitation who require more intensive therapy and/or assessment for lung transplant.
In conclusion, our data strongly suggest that the 6MWT provides important prognostic information in adult CF patients and should be routinely implemented. This test may be particularly suited for the prognostic evaluation of subjects with severe and very severe airflow limitation, as determined by an FEV 1 60% predicted. As previously reported in IPF and in COPD [23, 24] future studies should concentrate on repeating such analysis in multicenter prospective studies and in evaluating the value of longitudinal assessment of 6MWD to establish the minimal clinically important difference (MCID) associated with poor outcome. Further, worsening of gas exchange (i.e., SpO 2 90%) during the 6MWT in CF patients with severe airflow limitation who had no desaturation on previous 6MWT may help in assessment of candidates for lung transplant.
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